Clinical Trials
3 trialsNCT02036918 2020-03-31
Dendreon Lymph Node Biopsy in Metastatic Castrate-Resistant Prostate Cancer
Duke University
Phase 1 Completed
NCT02793219 2017-10-30
Provenge Followed by Docetaxel in Castration-Resistant Prostate Cancer
The University of Texas Health Science Center, Houston
Phase 2 Withdrawn
NCT02793765 2017-10-30
Docetaxel Followed by Provenge in Metastatic Prostate Cancer
The University of Texas Health Science Center, Houston
Phase 2 Withdrawn